Keisei Kawa

Summary

Affiliation: Osaka Medical Center for Cancer and Cardiovascular Diseases
Country: Japan

Publications

  1. ncbi request reprint Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease
    Keisei Kawa
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Osaka Izumi City 594 1101, Japan
    Crit Rev Oncol Hematol 44:251-7. 2002
  2. ncbi request reprint Epstein-Barr virus infection after unrelated cord blood transplantation: reactivation or reinfection?
    Keisei Kawa
    Division of Hematology Oncology, Osaka Medical Center, Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
    Int J Hematol 85:267-9. 2007
  3. ncbi request reprint Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease
    Keisei Kawa
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan
    Int J Hematol 78:24-31. 2003
  4. doi request reprint Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan
    Emiko Sato
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo cho, Izumi, Osaka, Japan
    Am J Hematol 83:721-7. 2008
  5. ncbi request reprint NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect
    Akihisa Sawada
    Department of Pediatric Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka 594 1101, Japan
    Am J Hematol 81:576-81. 2006
  6. doi request reprint Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation
    Shigeo Fuji
    Department of Hematology, NTT West Japan Osaka Hospital, Osaka, Japan
    Biol Blood Marrow Transplant 18:1407-14. 2012
  7. doi request reprint Feasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia
    Kayo Yamada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan
    Pediatr Blood Cancer 60:E60-2. 2013
  8. ncbi request reprint [The role of cord blood stem cell transplantation in children; a retrospective analysis of 39 cases in a single institute]
    Masami Inoue
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health
    Rinsho Ketsueki 47:1446-52. 2006
  9. doi request reprint Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia
    Akihisa Sawada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka 594 1101, Japan
    Leuk Res 33:1710-3. 2009
  10. doi request reprint Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program
    Hideki Muramatsu
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Biol Blood Marrow Transplant 16:231-8. 2010

Detail Information

Publications52

  1. ncbi request reprint Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease
    Keisei Kawa
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Osaka Izumi City 594 1101, Japan
    Crit Rev Oncol Hematol 44:251-7. 2002
    ..In this review, progress in the new therapeutic strategy is summarized, focusing on EBV-associated T/NK-cell lymphoproliferative disease (LPD), which is one of the heterogeneous EBV-associated disorder...
  2. ncbi request reprint Epstein-Barr virus infection after unrelated cord blood transplantation: reactivation or reinfection?
    Keisei Kawa
    Division of Hematology Oncology, Osaka Medical Center, Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
    Int J Hematol 85:267-9. 2007
  3. ncbi request reprint Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease
    Keisei Kawa
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan
    Int J Hematol 78:24-31. 2003
    ....
  4. doi request reprint Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan
    Emiko Sato
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo cho, Izumi, Osaka, Japan
    Am J Hematol 83:721-7. 2008
    ..563 +/- 0.124. Thus, in a substantial number of cases, EBV-associated T/NK-LPD can be cured by either allogeneic conventional stem cell transplantation or reduced-intensity stem cell transplantation...
  5. ncbi request reprint NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect
    Akihisa Sawada
    Department of Pediatric Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka 594 1101, Japan
    Am J Hematol 81:576-81. 2006
    ..However, the NK-cell repertoire is feasible for identifying EBV-infected NK-cell LPD and evaluating the treatment effect...
  6. doi request reprint Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation
    Shigeo Fuji
    Department of Hematology, NTT West Japan Osaka Hospital, Osaka, Japan
    Biol Blood Marrow Transplant 18:1407-14. 2012
    ..43; P = .019), and 1-year overall survival was superior in the PBSC group compared with the CB group (HR, 0.45; P = .036). Our results suggest that PBSC is the preferable source of stem cells in salvage HSCT for GF after CBT...
  7. doi request reprint Feasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia
    Kayo Yamada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan
    Pediatr Blood Cancer 60:E60-2. 2013
    ..Four of the five patients remain first complete remission for a median of 3.1 years after RIST. These results are preliminary, but suggest the feasibility and effectiveness of RIST with imatinib...
  8. ncbi request reprint [The role of cord blood stem cell transplantation in children; a retrospective analysis of 39 cases in a single institute]
    Masami Inoue
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health
    Rinsho Ketsueki 47:1446-52. 2006
    ..It should be emphasized that EBV-associated disease seems to be a suitable disease for CBSCT, because all of the 4 patients who underwent CBSCT are still in CR...
  9. doi request reprint Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia
    Akihisa Sawada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka 594 1101, Japan
    Leuk Res 33:1710-3. 2009
    ..0 years (range 3.8-6.6 years) with a 4-year event-free survival rate of 93.8+/-4.3%. This MRD-based treatment strategy seems to be highly successful and may improve the outcomes of children with ALL. A large study is warranted...
  10. doi request reprint Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program
    Hideki Muramatsu
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Biol Blood Marrow Transplant 16:231-8. 2010
    ..These findings provide important information for assessing the indications for and improving outcome in unrelated BMT for the treatment of pediatric CML...
  11. ncbi request reprint Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection
    Motohiko Okano
    Department of Pediatrics, Hokkaido University Hospital, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Am J Hematol 80:64-9. 2005
    ..Guidelines, derived mainly from the current literature and recent experiences with CAEBV in Japan, for diagnosing CAEBV are proposed to clarify this enigmatic disease...
  12. doi request reprint Multiplex polymerase chain reaction for six herpesviruses after hematopoietic stem cell transplantation
    Akihisa Sawada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan
    Pediatr Int 53:1010-7. 2011
    ....
  13. doi request reprint Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain
    Kayo Yamada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan
    Pediatr Blood Cancer 58:300-2. 2012
    ..However, severe transfusion-dependent bone marrow failure developed after five courses of 2-CdA. He underwent successful bone marrow transplantation from his HLA compatible sister with reduced intensity conditioning...
  14. ncbi request reprint [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation]
    Naoki Sakata
    Division of Hematology Oncology, Osaka Medical Center, Research Institute for Maternal and Child Health
    Rinsho Ketsueki 45:393-6. 2004
    ..Under these circumstances, RIST seems to be one of the curative treatments for the patients with CAEBV with minimal late side effects...
  15. ncbi request reprint Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation
    Hiroyasu Ogawa
    Department of Molecular Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan
    Int J Hematol 79:495-500. 2004
    ..In multivariate analysis, cytogenetics was found to be an independent predictor of relapse as well as of treatment failure...
  16. ncbi request reprint Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis
    Tomoko Kishimoto
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan
    Int J Hematol 78:453-6. 2003
    ..However, a greater number of patients and a longer observation period are needed before definitive conclusions can be drawn...
  17. ncbi request reprint Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection
    Naoki Sakata
    Department of Pediatrics, Kinki University School of Medicine, Osaka, Japan
    Pediatr Blood Cancer 50:924-7. 2008
    ..In situ hybridization for EBER revealed EBV-infected B-cells present in lesional tissue implying that interactions between EBV-infected B-cells and lesional Langerhans cells may be associated with the development of LCH...
  18. doi request reprint Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan
    Akihisa Sawada
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo, Izumi, Osaka, 594 1101, Japan
    Int J Hematol 98:223-30. 2013
    ..As a RIC regimen for CBT, 140 mg/m(2) melphalan with fludarabine and anti-lymphocyte globulin or anti-thymocyte globulin may be feasible, but further dosage optimization should be performed in controlled clinical trials. ..
  19. ncbi request reprint [Diagnosis and treatment of chronic active EBV infection]
    Keisei Kawa
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo cho, Izumi City, Osaka 594 1101
    Uirusu 52:257-60. 2002
  20. ncbi request reprint Nationwide survey of hemophagocytic lymphohistiocytosis in Japan
    Eiichi Ishii
    Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan
    Int J Hematol 86:58-65. 2007
    ..Although this nationwide survey establishes the heterogeneous characteristics of HLH, the results should be useful in planning prospective studies to identify the most effective therapy for each HLH subtype...
  21. ncbi request reprint Hepatoblastoma in children of extremely low birth weight: a report from a single perinatal center
    Takaharu Oue
    Department of Pediatric Surgery, Pediatrics and Neonatology, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
    J Pediatr Surg 38:134-7; discussion 134-7. 2003
    ..In the authors' institute, 5 infants of extremely low birth weight (ELBW) were found to have HB. The purpose of this study was to identify the characteristics of these infants to elucidate the pathogenesis of HB arising in ELBW infants...
  22. doi request reprint A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome
    Akira Kikuchi
    Division of Hematology Oncology, Saitama Children s Medical Center, Saitama, Japan
    Int J Hematol 90:492-500. 2009
    ..Rasburicase is effective and well tolerated for the management of hyperuricemia in Japanese pediatric patients at high risk of developing TLS...
  23. ncbi request reprint Clinical significance of minimal residual disease in childhood acute myeloid leukemia
    Takako Miyamura
    Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo cho, Izumi, Osaka 594 1101, Japan
    Int J Hematol 79:243-9. 2004
    ..4% +/- 9.8% (n = 26), a result that is encouraging and superior to other reported outcomes. Thus, an MRD-based treatment strategy together with conventional risk factors appears to be required for further improving the outcomes of AML...
  24. doi request reprint Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome
    Taizo Wada
    Department of Pediatrics, Graduate School of Medical Science, Kanazawa University, Japan
    Blood 112:1872-5. 2008
    ..These findings suggest that the clinical spectrum of XSCID is quite broad and includes atypical cases mimicking Omenn syndrome, and highlight the importance of revertant mosaicism as a possible cause for variable phenotypic expression...
  25. ncbi request reprint Botryoid Wilms' tumor of the renal pelvis extending into the bladder
    Akira Nagahara
    Department of Urology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan
    Urology 67:845.e15-7. 2006
    ..Histologic findings showed typical triphasic Wilms' tumor. Botryoid Wilms' tumor has been reported in only 16 cases in the literature and in only 3 cases extended into the bladder...
  26. ncbi request reprint Prognostic factors for chronic active Epstein-Barr virus infection
    Hiroshi Kimura
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    J Infect Dis 187:527-33. 2003
    ..59 vs. 0.87; P<.009). Patients with CAEBV with late onset of disease, thrombocytopenia, and T cell infection had significantly poorer outcomes...
  27. ncbi request reprint Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program
    Naoki Sakata
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
    Int J Hematol 80:174-82. 2004
    ....
  28. ncbi request reprint Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type
    Yoshinori Ito
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Higashi ku, Nagoya, Japan
    Clin Cancer Res 18:4183-90. 2012
    ....
  29. doi request reprint Detection of MYCN DNA in the cerebrospinal fluid for diagnosing isolated central nervous system relapse in neuroblastoma
    Tomiko Kimoto
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan
    Pediatr Blood Cancer 56:865-7. 2011
    ..The MYCN copy number in the CSF DNA was reflective of response to treatment...
  30. ncbi request reprint Megatherapy with hematopoietic stem cell rescue as a preoperative treatment in unresectable pediatric malignancies
    Takaharu Oue
    Department of Pediatric Surgery, Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
    J Pediatr Surg 38:130-3; discussion 130-3. 2003
    ..To elucidate the impact of preoperative MT on the treatments of pediatric advanced malignancies, the authors reviewed the timing of surgery, preoperative condition, postoperative recovery, and outcome...
  31. ncbi request reprint [Diagnosis and treatment for EBV-associated lymphoproliferative disease]
    Keisei Kawa
    Osaka Medical Center and Research Institute for Maternal and Child Health
    Nihon Rinsho 64:682-6. 2006
  32. ncbi request reprint NK-cell neoplasms in Japan
    Kazuo Oshimi
    Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
    Hematology 10:237-45. 2005
    ..In nasal NK-cell lymphoma, Epstein-Barr virus in tumor cells was detected in all patients tested, suggesting its causative role...
  33. ncbi request reprint [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease]
    Keisei Kawa
    Rinsho Ketsueki 49:390-6. 2008
  34. doi request reprint Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation
    Maho Koyama
    Int J Hematol 86:466-7. 2007
  35. ncbi request reprint The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors
    Yasuo Morishima
    Department of Hematology and Chemotherapy, the Division of Epidemiology and Prevention, Aichi Cancer Center, Japan
    Blood 99:4200-6. 2002
    ..Thus, the role of the HLA class I allele in unrelated bone marrow transplantation was elucidated. Notably, HLA-C alleles had a different mode from HLA-A or -B alleles for acute GVHD and survival...
  36. doi request reprint Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
    Motoko Yamaguchi
    Mie University Graduate School of Medicine, 2 174 Edobashi, Tsu, Mie 514 8507, Japan
    Cancer Sci 99:1016-20. 2008
    ..Although its safety and efficacy require further evaluation, we recommend a SMILE chemotherapy dose level of 1 for further clinical studies...
  37. ncbi request reprint [Encouraging results of stem cell transplantation following a melphalan-preceding intensified preparative regimen for refractory acute leukemia in children]
    Masami Inoue
    Department of Hematology Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health
    Rinsho Ketsueki 48:1470-7. 2007
    ..Four of six patients who did not have blasts in their peripheral blood before melphalan are in CR This method seems to be safe and effective for refractory acute leukemia...
  38. ncbi request reprint [The unification of hematopoietic stem cell transplantation registry in Japan and establishment of the TRUMP system]
    Yoshiko Atsuta
    Department of HSCT Data Management, Nagoya University, School of Medicine
    Rinsho Ketsueki 48:1462-9. 2007
    ..While enhancing domestic registries, the program seeks to coordinate with other hematopoietic cell transplant registries around the world to contribute to the development of registries throughout Asia...
  39. ncbi request reprint [Hematopoietic stem cell transplantation with conditioning regimens containing melphalan in pediatric patients with acute lymphoblastic leukemia]
    Takaharu Matsuyama
    Division of Hematology Oncology, Children s Medical Center, Japanese Red Cross Nagoya 1st Hospital
    Rinsho Ketsueki 43:527-37. 2002
    ..Contrary to that, treatment related toxic death was the most frequent cause of deaths in allogeneic-transplantation...
  40. ncbi request reprint Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification
    Michio Kaneko
    Study Group of Japan for Treatment of Advanced Neuroblastoma, and Department of Pediatric Surgery, University of Tsukuba, Tsukuba, Japan
    J Pediatr Hematol Oncol 24:613-21. 2002
    ....
  41. ncbi request reprint Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program
    Koji Izutsu
    Department of Cell Therapy and Transplantation Medicine, University of Tokyo, Japan
    Blood 103:1955-60. 2004
    ..Unrelated BMT should be considered as a treatment option for patients with high-risk NHL without an HLA-matched related donor...
  42. pmc Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus
    Takashi Nakayama
    Department of Microbiology, Kinki University School of Medicine, Osaka Sayama, Osaka 589 8511, Japan
    J Virol 78:1665-74. 2004
    ....
  43. ncbi request reprint Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism
    Tatsuo Ichinohe
    Department of Hematology Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Blood 104:3821-8. 2004
    ....
  44. ncbi request reprint [Pathophysiology of and therapy for hemophagocytic syndrome]
    Keisei Kawa
    Nihon Naika Gakkai Zasshi 93:1666-72. 2004
  45. ncbi request reprint Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement
    Ritsuro Suzuki
    Division of Molecular Medicine, Aichi Cancer Center, Nagoya, Japan
    Cancer 104:1022-31. 2005
    ..Blastic natural killer (NK) cell lymphoma/leukemia (BNKL) is an immature CD56-positive neoplasm, which was recognized recently and characterized by systemic proliferation of tumor cells including skin, lymph node, and bone marrow...
  46. ncbi request reprint [Diagnosis and treatment of hemophagocytic syndrome]
    Keisei Kawa
    Rinsho Ketsueki 46:418-23. 2005
  47. ncbi request reprint Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan
    Masahiro Imamura
    Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Int J Hematol 83:164-78. 2006
    ..OS for each disease was analyzed by patient age, stem cell source, donor type, disease status, and disease type. These data provide objective and valuable information for hematologists as well as for patients who need HCT...
  48. ncbi request reprint Irinotecan for children with relapsed solid tumors
    Toshiji Shitara
    Department of Hematology Oncology, Gunma Children s Medical Center, Seta gun, Gunma, Japan
    Pediatr Hematol Oncol 23:103-10. 2006
    ..3%) (neuro-blastoma, rhabdomyosarcoma, nephroblastoma, undifferentiated sarcoma, and leiomyosarcoma), and decrease in tumor marker in the other 2. Irinotecan appears promising, and could become included in the first-line treatment...
  49. ncbi request reprint Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan
    Ryoji Kobayashi
    Department of Paediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Br J Haematol 135:362-6. 2006
    ..Given the improved outcome for WAS patients following transplantation from an unrelated donor, we conclude that patients with WAS should receive SCT as soon as possible after diagnosis...
  50. ncbi request reprint Pediatric thyroid cancer arising after treatment for pleuropulmonary blastoma
    Takaharu Oue
    Department of Surgery, Division of Pediatric Surgery, Osaka University Graduate School of Medicine, 2 2 Yamadaoka, Suita, Osaka 565 0871, Japan
    Pediatr Blood Cancer 50:901-2. 2008
    ..The patient has remained tumor-free for 3 years. The etiology and treatment of the uncommon combination of pleuropulmonary blastoma and thyroid carcinoma is discussed...
  51. ncbi request reprint Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System
    Yoshiko Atsuta
    Department of HSCT Data Management, Nagoya University, School of Medicine, Nagoya, Japan
    Int J Hematol 86:269-74. 2007
    ..While enhancing domestic registries, the program seeks to coordinate with other hematopoietic cell transplantation registries around the world to contribute to the development of registries throughout Asia...
  52. ncbi request reprint Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation
    Makoto Yazaki
    Department of Paediatrics, Nagoya City University Medical School, 1 Kawasumi, Mizuho cho, Nagoya 467 8601, Japan
    Br J Haematol 117:893-8. 2002
    ....